For the past 7 years, pharmaceuticals that work as glucagon-like peptide 1 (GLP-1) receptor agonists have dominated the weight-loss and diabetes markets. These drugs, currently so ...

Cancer is becoming increasingly common among young people, with cases slowly and steadily rising every year for the past ...

A gene called KLF5 may be a key force behind the spread of pancreatic cancer—but not in the way scientists expected. Rather than mutating DNA, it rewires how genes are turned on and off, helping ...

Neuroendocrine cells are unique in their ability to act both as nerve cells and hormone-making cells.They're scattered throughout the body, including ...

HMC performed its first robotic Whipple procedure on a 42-year-old woman diagnosed with a pancreatic head neoplasm.

A recent meta-analysis reveals that artificial sweeteners do not increase the risk of cancer, despite years of skepticism.

According to the National Institutes of Health, nearly one in three adults in the US are overweight (30.7 per cent). Aside ...

There’s no denying how impressive the human body is. It can be incredibly strong, capable of pulling off amazing feats at the ...

The FDA has approved Foundayo, a new weight-loss pill that could give Eli Lilly an edge over other drugmakers. Here's how it ...

Far fewer Medicare Advantage patients underwent complex procedures - like pancreatic- or stomach-cancer surgeries - at high-quality centers. The gap in the kind of coverage these patients seek is ...

As cheaper versions enter the market and competition increases, the government is stepping in to regulate how these drugs are ...

Starting today, the Ozempic price in India will be cut by 36 percent, while Wegovy has seen a steeper 48 percent reduction — ...